Centiva Capital LP Cuts Stock Position in The Allstate Co. (NYSE:ALL)

Centiva Capital LP lessened its stake in shares of The Allstate Co. (NYSE:ALL - Free Report) by 33.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,787 shares of the insurance provider's stock after selling 1,377 shares during the period. Centiva Capital LP's holdings in Allstate were worth $537,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ALL. VSM Wealth Advisory LLC purchased a new stake in Allstate in the fourth quarter worth $25,000. Twin Tree Management LP purchased a new stake in Allstate in the fourth quarter worth $27,000. Vision Financial Markets LLC purchased a new stake in Allstate in the fourth quarter worth $29,000. Hopwood Financial Services Inc. purchased a new stake in Allstate in the fourth quarter worth $29,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in Allstate in the fourth quarter worth $29,000. Hedge funds and other institutional investors own 76.47% of the company's stock.

Allstate Stock Up 0.0%

NYSE ALL traded up $0.07 during trading on Tuesday, hitting $202.56. The company's stock had a trading volume of 1,077,460 shares, compared to its average volume of 1,615,344. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The company has a market cap of $53.64 billion, a PE ratio of 11.92, a P/E/G ratio of 1.01 and a beta of 0.32. The business's 50 day simple moving average is $199.12 and its 200-day simple moving average is $195.29. The Allstate Co. has a fifty-two week low of $156.66 and a fifty-two week high of $212.91.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing the consensus estimate of $3.98 by ($0.45). The business had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Allstate's revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.13 EPS. On average, equities analysts anticipate that The Allstate Co. will post 18.74 EPS for the current fiscal year.

Allstate Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 10th were issued a dividend of $1.00 per share. This is an increase from Allstate's previous quarterly dividend of $0.92. The ex-dividend date was Monday, March 10th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.97%. Allstate's payout ratio is 27.32%.

Allstate declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, February 26th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the insurance provider to purchase up to 3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's management believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ALL. Keefe, Bruyette & Woods raised their price target on Allstate from $228.00 to $235.00 and gave the company an "outperform" rating in a research note on Wednesday, May 7th. Evercore ISI raised their price target on Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Barclays cut their price target on Allstate from $183.00 to $172.00 and set an "underweight" rating on the stock in a research note on Friday, April 11th. Argus upgraded Allstate from a "hold" rating to a "buy" rating in a report on Monday, March 3rd. Finally, JPMorgan Chase & Co. upped their price objective on Allstate from $217.00 to $222.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $225.20.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.